Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AV.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AV.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.309NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.309NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.309NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.105NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.105NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.105NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.307NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.307NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.307NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.171NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.171NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.171NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.57NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.57NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.57NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.67NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.67NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.279NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.279NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.279NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.67NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.67NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used